Furthermore, we observed that rs10057302 (TIM-3) genotypes tend to be differently distributed between ccRCC patients and controls (p = 0.071, Table 1), where carriers of the rs10057302 A allele (AC + AA genotypes) had two times lower ccRCC risk (OR = 0.45; 95% CI 0.22–0.95; p = 0.027) than individuals with the CC genotype. Here, HAVCR2 is linked to nonpapillary renal cell carcinoma.